BioCardia share price logo

BioCardia

NASDAQ: BCDA

$0.92

+0.02

(+2.18%)

as on

BioCardia Stock Performance

as on November 4, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.90
    $0.98
    downward going graph

    2.34%

    Downside

    6.34%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.75
    $1.80
    downward going graph

    18.62%

    Downside

    95.31%

    Upside

    downward going graph

BioCardia share price movements today

Previous Close
$0.90
Open
$0.94
Volume
346.5K
Market Cap
$13.0M
Day's Low - High
$0.90 - $0.98
52 Week Low - High
$0.75 - $1.80

BioCardia Historical Returns

1 Month Return
-13.28 %
3 Month Return
+ 8.51 %
1 Year Return
-35.12 %
3 Year Return
-84.97 %
5 Year Return
-97.86 %

BioCardia Stock Fundamentals & Key Indicators

Check BioCardia market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.0M

EPS (TTM)

-0.76

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.13

Industry PE ratio

-3.13

PEG Ratio

-0.01

EBITDA

-7.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-569.36%

BioCardia vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioCardia with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BioCardia image
BioCardia
Buy$13.0M-97.86%-1.130.00%0.00%
Moderna image
Moderna
Neutral$88.5B-36.16%-27.78-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$141.7B192.56%32.2786.04%0.00%
Regeneron image
Regeneron
Buy$95.5B47.41%19.7685.77%0.40%

Stock Returns calculator for BioCardia Stock including INR - Dollar returns

The BioCardia stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

BioCardia investment value today

Current value as on today

₹70,798

Returns

-₹29,202

(-29.2%)

Returns from BioCardia Stock

-₹33,698 (-33.7%)

Dollar Impact

₹4,496 (+4.5%)

Analyst Recommendation on BioCardia Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for BioCardia. Average target price of $15.5

BioCardia Share Price Target

Get share price movements and forecasts by analysts on BioCardia.

What analysts predicted

94.05%UPSIDE

Target Price

$15.5

Current Price

$0.9216

Analyzed by

1 Analysts

High

$25

Target

$15.50

Low

$25

BioCardia target price $15.5, a slight upside of 94.05% compared to current price of $0.9216. According to 1 analysts rating.

Indian Investors' Interest in BioCardia Stock

Search interest for BioCardia Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:43% versus previous 30 day period

BioCardia Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
-
-
-
-
-
-
-
-
Gross Profit
-1
0
0
-1
-1
-1
0
0
0
0
Operating Income
-2
-1
-1
-2
-2
-2
-1
-2
-2
-1
EBITDA
-2
-1
-1
-2
-2
-2
-1
-1
-2
-1
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-1
-1
-2
-2
-2
-1
-1
-2
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
-1
-1
-2
-2
-2
-1
-1
-2
-1
Net Profit Margin
-2156.36%
-26566.67%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

BioCardia Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
1
1
0
0
-
Gross Profit
0
0
0
0
0
-7
-7
-4
0
Operating Income
-12
-14
-14
-15
-12
-11
-11
-8
-8
EBITDA
-12
-13
-14
-14
-12
-11
-11
-7
-7
Interest Expense
-
-
0
0
-
0
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-13
-14
-15
-12
-11
-11
-7
-8
Income Tax Expense
-
0
-
-
-
-
-
-
-
Net Income
-12
-13
-14
-15
-12
-11
-11
-7
-8
Net Profit Margin
-44.05%
17.28%
49.58%
97.24%
36.95%
-553.40%
-1519.71%
-7463.79%
0.00%

BioCardia Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-2
-1
-1
-2
-2
-2
-1
-1
-2
-1
Operating Cash Flow
-1
-1
-2
-2
-1
-1
-1
-2
-1
-1
Investing Cash Flow
-
0
0
0
-
0
-
0
0
-
Financing Cash Flow
1
1
6
0
0
1
5
0
0
4
Change in Cash
0
0
3
-2
-1
0
4
-2
-1
3

BioCardia Annual Cash Flow

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-12
-13
-14
-15
-12
-11
-11
-7
-8
Operating Cash Flow
-8
-11
-9
-12
-10
-10
-9
-8
-7
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
3
9
28
1
5
3
9
7
Change in Cash
-8
-7
0
15
-8
-5
-6
1
0

Global Institutional Holdings in BioCardia

Check out the Institutions with significant holdings in BioCardia.

Funds
Holdings
SIMON H STERTZER
5.44%
Andrew Scott Blank
4.20%
Peter Altman
2.55%
VANGUARD INDEX FUNDS
0.82%
Vanguard
0.82%
See all

BioCardia News & Key Events

  • img

    Today's Timeline - 19 October

    Mon, 07:11 PM

    -

    BioCardia announces FDA acceptance of Helix pre-submission package for marketing clearance, with no safety concerns raised.

Insights on BioCardia

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -2.25M → -1.61M (in $), with an average increase of 40.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 194.6% return, outperforming this stock by 279.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 861.9% return, outperforming this stock by 892.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, BCDA stock has moved down by -84.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 58.0K → -58.0K (in $), with an average decrease of 200.0% per quarter

About BioCardia

BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia. Additionally, BioCardia is advancing an allogeneic cell therapy program, also targeting cardiac and pulmonary conditions. The company is further exploring a specific allogeneic cell therapeutic platform. This investigational treatment, derived from culture-expanded mesenchymal cells sourced from bone marrow, is currently undergoing Phase I/II trials for patients suffering from ischemic systolic heart failure. Beyond its therapeutic candidates, BioCardia also provides innovative delivery solutions. These include the Helix biotherapeutic delivery system, engineered to precisely administer treatments directly into the heart muscle via an internal penetrating helical needle, and a line of Morph deflectable guides and sheaths. BioCardia maintains its headquarters in Sunnyvale, California.
OrganisationBioCardia
Headquarters320 Soquel Way, Sunnyvale, CA, 94085, US
IndustryBiotechnology
CEOPeter A. Altman

Key Management of BioCardia

Name

Title

Mr. David McClung

Chief Financial Officer

Mr. Edward M. Gillis

Senior Vice President of Devices

Ms. Miranda Peto Benvenuti

Investor Relations Executive

Dr. Peter A. Altman Ph.D.

CEO, President & Director

FAQs

What is BioCardia share price today?

BioCardia share price today is $0.92 as on at the close of the market. BioCardia share today touched a day high of $0.98 and a low of $0.90.

What is the 52 week high and 52 week low for BioCardia share?

BioCardia share touched a 52 week high of $1.80 on and a 52 week low of $0.75 on . BioCardia stock price today i.e. is closed at $0.92,which is 48.80% down from its 52 week high and 22.88% up from its 52 week low.

What is BioCardia's market capitalisation today?

BioCardia market capitalisation is $0.00T as on .

How to invest in BioCardia Stock (BCDA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioCardia on INDmoney app. Click on Buy button.

What is the minimum amount required to buy BioCardia Stock (BCDA) from India?

Indian investors can start investing in BioCardia (BCDA) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in BioCardia stock (as per the Rupee-Dollar exchange rate as on ). Based on BioCardia share’s latest price of $0.92 as on November 4, 2026 at 8:45 am IST, you will get 10.8507 shares of BioCardia. Learn more about fractional shares .

What are the returns that BioCardia has given to Indian investors in the last 5 years?

BioCardia stock has given -97.86% share price returns and 27.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?